BLOOMINGTON - State and local officials will Friday join executives from New Jersey-based Catalent Inc. (NYSE: CTLT) to break ground on a new drug product manufacturing facility in Bloomington. The project is part of a $100 million expansion announced in January that is expected to create up to 200 jobs by the end of 2024.

The Indiana Economic Development Corp. says the new facility will increase Catalent's finish/fill capacity by 79,000 square feet. The company will use the new space to house a high-speed vial line, a high-speed flexible syringe/cartridge line, a fully-automated vial inspection machine and various associated services and support areas.

Construction on the new facility is expected to be complete by June 2020. Governor Eric Holcomb and Bloomington Deputy Mayor Mick Renneisen will be on hand for the groundbreaking ceremony, which is scheduled to begin at 11:00 a.m.

Catalent recently completed a $14 million investment to renovate its Bloomington Biologics packaging capabilities and capacity, according to the IEDC.